Avory & Company’s Xometry XMTR Stock Holding History

Avory & Company’s Portfolio XMTR Stock Details XMTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,184	Closed	-$249K	–	50
2025 Q4	$249K	Buy	4,184 +94	+2%	+$5.3K	0.16%	34
2025 Q3	$223K	Buy	+4,090	New	+$177K	0.13%	30

Other funds holding XMTR

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Avory & Company's XMTR Position: Q1 2026 in Review

Avory & Company sold out of Xometry (XMTR) in Q1 2026, closing a stake of 4,184 shares — an estimated $249K sold.

Avory & Company first reported a position in XMTR in Q3 2025 and held it in 2 quarters. The position peaked at $249K in Q4 2025. 249 funds tracked by Wall St. Rank hold XMTR as of Q1 2026.

Avory & Company reported no remaining Xometry position as of Q1 2026 after selling out during the quarter.
Avory & Company sold 4,184 Xometry shares in Q1 2026, an estimated $249K.
Avory & Company first reported a position in Xometry in Q3 2025 and held it in 2 quarters.
Avory & Company's Xometry position peaked at $249K in Q4 2025.
249 funds tracked by Wall St. Rank held Xometry as of Q1 2026.

Based on Avory & Company's 13F filing for Q1 2026, filed 29 Apr 2026.